• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

四种原发性醛固酮增多症确诊试验的比较:无金标准情况下的贝叶斯分析。

Comparison of four confirmatory tests for the diagnosis of primary aldosteronism: Bayesian analysis in the absence of a gold standard.

机构信息

Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Department of Medicine, Monash University, Clayton, Victoria, Australia.

出版信息

Endocrine. 2024 Sep;85(3):1417-1424. doi: 10.1007/s12020-024-03885-2. Epub 2024 Jul 15.

DOI:10.1007/s12020-024-03885-2
PMID:39009922
Abstract

BACKGROUND

Captopril challenge test (CCT), seated saline infusion test (SSIT), oral sodium loading test (OSLT) and fludrocortisone suppression test (FST) are widely used diagnostic tests for primary aldosteronism (PA). These tests differ in terms of safety and complexity. Whether the simpler tests (CCT and SSIT) are comparable in diagnostic performance to the more complex ones (FST and OSLT) is unclear.

PURPOSE

To compare the diagnostic accuracy of the four tests.

METHODS

This is a retrospective study of hypertensive patients who were screened for PA and completed at least one confirmatory test. The patients were divided into two cohorts: one including those who completed one to three tests was used for the estimation of sensitivity and specificity. The other including those who completed four tests was used for the comparison of accuracy. Bayesian method was used to obtain the sensitivity, specificity, and Youden index of each test.

RESULTS

The study included 1011 hypertensive patients. Among them, 895 patients completed one to three tests (including 889 CCT, 605 FST, 611 SSIT and 69 OSLT), and 116 patients completed four tests. SSIT had the highest sensitivity of 0.82(95% CI 0.78-0.86) but the lowest specificity of 0.76(0.70-0.80). OSLT had the lowest sensitivity of 0.65(0.56-0.75) but the highest specificity of 0.91(0.82-0.96). The sensitivity and specificity were 0.78 (95% CI, 0.75-0.82), 0.82 (95% CI, 0.78-0.85), for CCT, and 0.77 (95% CI, 0.73-0.81), 0.87 (95% CI, 0.82-0.91) for FST, respectively. The Youden index was not significantly different among the four tests[0.60(0.55-0.65) for CCT; 0.58(0.51-0.64) for SSIT; (0.64(0.57-0.69) for FST; 0.56(0.43-0.67) for OSLT].

CONCLUSION

The accuracy of simpler tests is comparable to the more complex ones. Considering the safety and simplicity of CCT, it may be a reasonable first choice when confirming the diagnosis of PA.

摘要

背景

卡托普利激发试验(CCT)、坐位生理盐水输注试验(SSIT)、口服钠负荷试验(OSLT)和氟氢可的松抑制试验(FST)是原发性醛固酮增多症(PA)的常用诊断试验。这些试验在安全性和复杂性方面存在差异。较简单的试验(CCT 和 SSIT)与更复杂的试验(FST 和 OSLT)在诊断性能上是否相当尚不清楚。

目的

比较这四种试验的诊断准确性。

方法

这是一项回顾性研究,纳入了接受 PA 筛查并至少完成一项确认性试验的高血压患者。患者被分为两组:一组包括完成一至三项试验的患者,用于估计敏感性和特异性;另一组包括完成四项试验的患者,用于比较准确性。采用贝叶斯方法获得每种试验的敏感性、特异性和约登指数。

结果

该研究纳入了 1011 名高血压患者。其中,895 名患者完成了一至三项试验(包括 889 例 CCT、605 例 FST、611 例 SSIT 和 69 例 OSLT),116 名患者完成了四项试验。SSIT 的敏感性最高,为 0.82(95%CI 0.78-0.86),但特异性最低,为 0.76(0.70-0.80)。OSLT 的敏感性最低,为 0.65(0.56-0.75),但特异性最高,为 0.91(0.82-0.96)。CCT 的敏感性和特异性分别为 0.78(95%CI,0.75-0.82)、0.82(95%CI,0.78-0.85),FST 分别为 0.77(95%CI,0.73-0.81)、0.87(95%CI,0.82-0.91)。四种试验的约登指数无显著差异[CCT 为 0.60(0.55-0.65);SSIT 为 0.58(0.51-0.64);FST 为 0.64(0.57-0.69);OSLT 为 0.56(0.43-0.67)]。

结论

较简单试验的准确性与更复杂试验相当。考虑到 CCT 的安全性和简便性,它可能是确认 PA 诊断的合理首选。

相似文献

1
Comparison of four confirmatory tests for the diagnosis of primary aldosteronism: Bayesian analysis in the absence of a gold standard.四种原发性醛固酮增多症确诊试验的比较:无金标准情况下的贝叶斯分析。
Endocrine. 2024 Sep;85(3):1417-1424. doi: 10.1007/s12020-024-03885-2. Epub 2024 Jul 15.
2
Seated Saline Suppression Test Is Comparable With Captopril Challenge Test for the Diagnosis of Primary Aldosteronism: A Prospective Study.坐位生理盐水抑制试验与卡托普利激发试验诊断原发性醛固酮增多症的比较:一项前瞻性研究。
Endocr Pract. 2021 Apr;27(4):326-333. doi: 10.1016/j.eprac.2020.10.016. Epub 2020 Dec 14.
3
Confirmatory Tests for the Diagnosis of Primary Aldosteronism: A Prospective Diagnostic Accuracy Study.原发性醛固酮增多症诊断的确认性试验:一项前瞻性诊断准确性研究。
Hypertension. 2018 Jan;71(1):118-124. doi: 10.1161/HYPERTENSIONAHA.117.10197. Epub 2017 Nov 20.
4
A combination of captopril challenge test after saline infusion test improves diagnostic accuracy for primary aldosteronism.盐水输注试验后卡托普利激发试验联合应用提高了原发性醛固酮增多症的诊断准确性。
Clin Endocrinol (Oxf). 2020 Feb;92(2):131-137. doi: 10.1111/cen.14134. Epub 2019 Dec 17.
5
Confirmatory tests for the diagnosis of primary aldosteronism: A systematic review and meta-analysis.用于原发性醛固酮增多症诊断的确认性试验:系统评价和荟萃分析。
Clin Endocrinol (Oxf). 2019 May;90(5):641-648. doi: 10.1111/cen.13943. Epub 2019 Feb 26.
6
[The application of captopril challenge test in the diagnosis of primary aldosteronism].[卡托普利激发试验在原发性醛固酮增多症诊断中的应用]
Zhonghua Nei Ke Za Zhi. 2017 Jun 1;56(6):402-408. doi: 10.3760/cma.j.issn.0578-1426.2017.06.004.
7
Seated saline infusion test in predicting subtype diagnosis of primary aldosteronism.坐位盐水输注试验在原发性醛固酮增多症亚型诊断中的预测作用
Clin Endocrinol (Oxf). 2019 Dec;91(6):737-742. doi: 10.1111/cen.14111. Epub 2019 Nov 6.
8
Parameters of captopril challenge test can predict results of other confirmatory tests for primary aldosteronism and propose the next test to be done.卡托普利激发试验的参数可以预测原发性醛固酮增多症的其他确证性试验的结果,并提出下一步要进行的检查。
Endocr J. 2020 Jul 28;67(7):741-750. doi: 10.1507/endocrj.EJ19-0498. Epub 2020 Apr 3.
9
Captopril challenge test: an underutilized test in the diagnosis of primary aldosteronism.卡托普利激发试验:一种在原发性醛固酮增多症诊断中未得到充分利用的检查。
Endocr Connect. 2024 Jan 24;13(3). doi: 10.1530/EC-23-0445. Print 2024 Mar 1.
10
The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population.卡托普利激发试验在中国人群中诊断原发性醛固酮增多症的应用
BMC Endocr Disord. 2019 Jun 24;19(1):65. doi: 10.1186/s12902-019-0390-3.

引用本文的文献

1
Discordance and shortcomings of aldosterone suppression tests in primary aldosteronism.原发性醛固酮增多症中醛固酮抑制试验的不一致性和不足之处。
Eur J Endocrinol. 2025 Aug 29;193(3):348-358. doi: 10.1093/ejendo/lvaf170.
2
Comparison of different criteria of captopril challenge test for the diagnosis of primary aldosteronism.卡托普利激发试验不同诊断标准对原发性醛固酮增多症诊断的比较
Endocrine. 2025 Jul 5. doi: 10.1007/s12020-025-04326-4.
3
ACE Inhibition to Distinguish Low-Renin Hypertension From Primary Aldosteronism.通过血管紧张素转换酶抑制来鉴别低肾素性高血压与原发性醛固酮增多症。

本文引用的文献

1
Detecting primary aldosteronism in Australian primary care: a prospective study.澳大利亚初级医疗保健中原发性醛固酮增多症的检测:一项前瞻性研究。
Med J Aust. 2022 May 2;216(8):408-412. doi: 10.5694/mja2.51438. Epub 2022 Feb 25.
2
Development of a Prediction Score to Avoid Confirmatory Testing in Patients With Suspected Primary Aldosteronism.开发一种预测评分系统,以避免对疑似原发性醛固酮增多症患者进行确证性检测。
J Clin Endocrinol Metab. 2021 Mar 25;106(4):e1708-e1716. doi: 10.1210/clinem/dgaa974.
3
The Unrecognized Prevalence of Primary Aldosteronism.
Hypertension. 2025 Jun;82(6):1046-1055. doi: 10.1161/HYPERTENSIONAHA.125.24711. Epub 2025 Mar 31.
原发性醛固酮增多症未被认识的患病率
Ann Intern Med. 2020 Oct 20;173(8):683. doi: 10.7326/L20-1097.
4
Primary Aldosteronism in Patients in China With Recently Detected Hypertension.中国近期确诊高血压患者中的原发性醛固酮增多症。
J Am Coll Cardiol. 2020 Apr 28;75(16):1913-1922. doi: 10.1016/j.jacc.2020.02.052.
5
Diagnostic test evaluation methodology: A systematic review of methods employed to evaluate diagnostic tests in the absence of gold standard - An update.诊断测试评估方法学:系统综述在缺乏金标准的情况下用于评估诊断测试的方法 - 更新版。
PLoS One. 2019 Oct 11;14(10):e0223832. doi: 10.1371/journal.pone.0223832. eCollection 2019.
6
Comparison of Seated With Recumbent Saline Suppression Testing for the Diagnosis of Primary Aldosteronism.坐位与卧位盐水抑制试验诊断原发性醛固酮增多症的比较。
J Clin Endocrinol Metab. 2018 Nov 1;103(11):4113-4124. doi: 10.1210/jc.2018-01394.
7
Age-Related Cutoffs of Plasma Aldosterone/Renin Concentration for Primary Aldosteronism Screening.原发性醛固酮增多症筛查中血浆醛固酮/肾素浓度的年龄相关临界值。
Int J Endocrinol. 2018 Jul 16;2018:8647026. doi: 10.1155/2018/8647026. eCollection 2018.
8
Evaluation of the Saline Infusion Test and the Captopril Challenge Test in Chinese Patients With Primary Aldosteronism.中文原发性醛固酮增多症患者盐水输注试验和卡托普利激发试验的评价。
J Clin Endocrinol Metab. 2018 Mar 1;103(3):853-860. doi: 10.1210/jc.2017-01530.
9
Confirmatory Tests for the Diagnosis of Primary Aldosteronism: A Prospective Diagnostic Accuracy Study.原发性醛固酮增多症诊断的确认性试验:一项前瞻性诊断准确性研究。
Hypertension. 2018 Jan;71(1):118-124. doi: 10.1161/HYPERTENSIONAHA.117.10197. Epub 2017 Nov 20.
10
Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice.原发性醛固酮增多症在基层医疗实践中的患病率和临床表现。
J Am Coll Cardiol. 2017 Apr 11;69(14):1811-1820. doi: 10.1016/j.jacc.2017.01.052.